SYVN1

E3 ubiquitin-protein ligase synoviolin · Q86TM6 · SYVN1 on Sugi Atlas →

0 patent compounds predicted against SYVN1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SYVN1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World PHASE4UNKNOWN
Serum Calprotectin Level in Patients With Rheumatoid Arthritis and Osteoarthritis PHASE4UNKNOWN
Molecular Biomarkers Associated With Degenerative Joint Disease in the Knee nanCOMPLETED
MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA nanUNKNOWN
Identification of Novel Molecular Targets for Rheumatoid Arthritis Patients nanUNKNOWN
Screening of Specific Genes for Pigmented Villous Nodular Synovitis nanCOMPLETED
Genetics of Rheumatoid Arthritis nanCOMPLETED
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions nanRECRUITING
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Phenotype/Genotype Correlation in a Family With Early Onset Osteoarthritis nanCOMPLETED
Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset nanWITHDRAWN
The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid Arthritis nanUNKNOWN
Genetic Determinants of Ankylosing Spondylitis Severity nanCOMPLETED
Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis nanRECRUITING
CTHRC1: A Biomarker for Evaluation of Rheumatoid Arthritis Disease Activity nanUNKNOWN
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin nanUNKNOWN
Identification of Molecular Marker of Coagulase-negative Staphylococci for the Diagnosis of Prosthetic Joint Infections nanUNKNOWN
Translating Articular Biomarkers Into Diagnoses nanRECRUITING
Genetic Registry for Rheumatoid Arthritis nanCOMPLETED
Genetics and Mechanisms of Rheumatoid Arthritis nanCOMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Exercise on microRNA in Rheumatoid Arthritis nanCOMPLETED
Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis nanRECRUITING
Genetic Analysis of Psoriasis and Psoriatic Arthritis nanCOMPLETED
18F-FDG PET/TC in TIR3A e TIR3B nanENROLLING_BY_INVITATION
The Genetic and the Functional Study of DNA Repair System and the Susceptibility to Rheumatoid Arthritis nanCOMPLETED
Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis nanUNKNOWN
GARM II: A Study on the Genetics of Age-related Maculopathy nanACTIVE_NOT_RECRUITING
Mechanism of Action of Ustekinumab in Psoriatic Arthritis nanUNKNOWN
Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for Arthritis nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SYVN1 binder may also engage these)

ProteinNameSimilarity
Q9DBY1 1.000 Q9DBY1 →
Q6NRL6 0.991 Q6NRL6 →
Q803I8 0.989 Q803I8 →
Q5XHH7 0.987 Q5XHH7 →
Q90YH8 0.966 Q90YH8 →
Q6P4P2 0.965 Q6P4P2 →
Q5PQS6 0.964 Q5PQS6 →
Q8IWV8 0.964 Q8IWV8 →
Q6R755 0.962 Q6R755 →
Q5R7S4 0.962 Q5R7S4 →
Q8WXG6 0.962 Q8WXG6 →
Q9JJV8 0.961 Q9JJV8 →
P22682 0.961 P22682 →
Q9UPW6 0.961 Q9UPW6 →
Q9H0W8 0.961 Q9H0W8 →
Q3UHE1 0.960 Q3UHE1 →
A9JRA0 0.960 A9JRA0 →
BCL2 Apoptosis regulator Bcl-2 0.960 landscape →
Q6P8G8 0.960 Q6P8G8 →
Q01826 0.960 Q01826 →
Q80U28 0.960 Q80U28 →
P10417 0.960 P10417 →
Q5RH73 0.960 Q5RH73 →
Q5R9W1 0.960 Q5R9W1 →
Q9H3S7 0.960 Q9H3S7 →
Q60611 0.960 Q60611 →
O60337 0.960 O60337 →
Q96D05 0.960 Q96D05 →
Q4KUS2 0.960 Q4KUS2 →
Q8C561 0.959 Q8C561 →